The Chicago Entrepreneur

[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width="100%" palette="financial-light"]
Menu
Top Stories

Viking Therapeutics’ stock boosted by positive data from trial of treatment for rare metabolic disorder X-ALD

Viking, which is also developing a weight-loss pill, has a buy rating from all 13 analysts offering coverage.

Previous post The U.S. fertility rate is falling. Is there anything we can do?
Next post Wall Street’s most bearish firm on stocks says there’s a chance of an upswing

More Stories